NASDAQ: ICPT       Intercept Pharmaceuticals
Last Price Today's Change   Day's Range   Trading Volume
108.09   -2.16 (1.96%)  106.81 - 110.44  192,101


Avg Volume (4 weeks):569,116
4 Weeks Range:105.57 - 125.00
4 Weeks Price Volatility (%):
52 Weeks Range:56.76 - 131.87
52 Weeks Price Volatility (%):
Average Price Target: 350.00
Price Target Upside/Downside: +241.91


No recent Headlines for this stock.

Business Background

Intercept Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases. The Company's product candidates have the potential to treat orphan and more prevalent diseases for which there are limited therapeutic solutions. The Company's product candidate, obeticholic acid (OCA), is a bile acid analog, a chemical substance that has a structure based on a naturally occurring human bile acid that selectively binds to and activates the farnesoid X receptor (FXR). In addition to OCA, it is developing other bile acid analog compounds targeting FXR and a second dedicated bile acid receptor called TGR5, which is a target of interest for the treatment of type 2 diabetes and other gastrointestinal indications. The Company is also developing other products INT-767 for the treatment of fibrosis and INT-777 for the treatment of type 2 diabetes.

  Be the first to like this.


2018  3476  572  2906 

Top 10 Active Counters
 CELG 108.24+0.11 
 AVP 5.60-0.05 
 NIO 4.591+0.221 
 AABA 19.630.00 
 VIAB 24.22+0.75 
 BBT 54.24+0.75 
 TTNP 0.298+0.048 
 ACB 2.135-0.015 
 CHK 0.669-0.021 
 STI 70.13+0.87 
Partners & Brokers